{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T23:07:30Z","timestamp":1764976050359,"version":"3.46.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":50,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Pacing and Electrophysiology Journal"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ipej.2025.10.008","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:40:04Z","timestamp":1761090004000},"page":"359-369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antithrombotic management in left sided- ablation and appendage device-closure procedures"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3254-4841","authenticated-orcid":false,"given":"Sheetal Vasundara","family":"Mathai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6355-8843","authenticated-orcid":false,"given":"Fengwei","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6508-4047","authenticated-orcid":false,"given":"Luigi","family":"Di Biase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ipej.2025.10.008_bib1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2147\/CLEP.S47385","article-title":"Epidemiology of atrial fibrillation: european perspective","volume":"6","author":"Zoni-Berisso","year":"2014","journal-title":"Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.ipej.2025.10.008_bib2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ipej.2025.10.008_bib3","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart disease and stroke Statistics-2022 update: a report from the American heart association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ipej.2025.10.008_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2025.05.048","article-title":"2025 SCAI\/HRS clinical practice guidelines on transcatheter left atrial appendage occlusion","author":"Goldsweig","year":"2025","journal-title":"Heart Rhythm"},{"issue":"36","key":"10.1016\/j.ipej.2025.10.008_bib5","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the european association for cardio-thoracic surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"issue":"24","key":"10.1016\/j.ipej.2025.10.008_bib6","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.jcin.2016.10.035","article-title":"Transseptal techniques for emerging structural heart interventions","volume":"9","author":"Alkhouli","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"10.1016\/j.ipej.2025.10.008_bib7","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jacep.2024.10.024","article-title":"State of the art in left atrial appendage occlusion","volume":"11","author":"Garg","year":"2025","journal-title":"JACC Clin Electrophysiol"},{"issue":"2","key":"10.1016\/j.ipej.2025.10.008_bib8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.clinthera.2023.09.028","article-title":"Antithrombotic treatment after transcatheter valve interventions: current status and future directions","volume":"46","author":"Maznyczka","year":"2024","journal-title":"Clin Ther"},{"issue":"2","key":"10.1016\/j.ipej.2025.10.008_bib9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/europace\/euz258","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update","volume":"22","author":"Glikson","year":"2020","journal-title":"Europace"},{"issue":"22","key":"10.1016\/j.ipej.2025.10.008_bib10","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1161\/01.CIR.0000039327.11661.16","article-title":"Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke","volume":"106","author":"Cai","year":"2002","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ipej.2025.10.008_bib11","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1161\/01.STR.0000023889.84649.3D","article-title":"Is the hypercoagulable state in atrial fibrillation mediated by vascular endothelial growth factor?","volume":"33","author":"Chung","year":"2002","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.ipej.2025.10.008_bib12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jamacardio.2022.5449","article-title":"Association of left atrial strain with ischemic stroke risk in older adults","volume":"8","author":"Mannina","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"6","key":"10.1016\/j.ipej.2025.10.008_bib13","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1161\/STROKEAHA.115.008711","article-title":"Left atrial enlargement and stroke recurrence","volume":"46","author":"Yaghi","year":"2015","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.ipej.2025.10.008_bib14","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1161\/STROKEAHA.116.013351","article-title":"Poor outcome of stroke patients with atrial fibrillation in the presence of coexisting spontaneous echo contrast","volume":"47","author":"Yoo","year":"2016","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.ipej.2025.10.008_bib15","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.hrthm.2011.02.026","article-title":"Stiff left atrial syndrome after catheter ablation for atrial fibrillation: clinical characterization, prevalence, and predictors","volume":"8","author":"Gibson","year":"2011","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.ipej.2025.10.008_bib16","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/europace\/eux274","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"20","author":"Calkins","year":"2018","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.ipej.2025.10.008_bib17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/STROKEAHA.111.627067","article-title":"Left atrial catheter ablation and ischemic stroke","volume":"43","author":"Haeusler","year":"2012","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.ipej.2025.10.008_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad151","article-title":"Silent cerebral lesions following catheter ablation for atrial fibrillation: a state-of-the-art review","volume":"25","author":"Calvert","year":"2023","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.ipej.2025.10.008_bib19","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jacc.2023.09.831","article-title":"Antithrombotic therapy for patients undergoing cardiac electrophysiological and interventional procedures: JACC state-of-the-art review","volume":"83","author":"Di Biase","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.ipej.2025.10.008_bib20","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.hrthm.2024.03.017","article-title":"2024 european heart rhythm association\/heart rhythm society\/asia Pacific heart rhythm society\/latin American heart rhythm society expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"21","author":"Tzeis","year":"2024","journal-title":"Heart Rhythm"},{"issue":"23","key":"10.1016\/j.ipej.2025.10.008_bib21","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1016\/j.jacc.2021.04.036","article-title":"Prevalence of left atrial thrombus in anticoagulated patients with atrial fibrillation","volume":"77","author":"Lurie","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ipej.2025.10.008_bib22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jcin.2019.08.054","article-title":"Expert recommendations on cardiac computed tomography for planning transcatheter left atrial appendage occlusion","volume":"13","author":"Korsholm","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ipej.2025.10.008_bib23","doi-asserted-by":"crossref","DOI":"10.15420\/aer.2023.29","article-title":"Intracardiac echocardiography-guided left atrial appendage occlusion","volume":"13","author":"Diaz","year":"2024","journal-title":"Arrhythmia Electrophysiol Rev"},{"issue":"8","key":"10.1016\/j.ipej.2025.10.008_bib24","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/europace\/euv190","volume":"17","author":"Sticherling","year":"2015","journal-title":"EP Europace"},{"issue":"21","key":"10.1016\/j.ipej.2025.10.008_bib25","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1161\/CIRCULATIONAHA.117.031343","article-title":"Use of intracardiac echocardiography in interventional cardiology","volume":"137","author":"Enriquez","year":"2018","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ipej.2025.10.008_bib26","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10840-020-00844-5","article-title":"Does the use of intracardiac echocardiography during atrial fibrillation catheter ablation improve outcomes and cost? A nationwide 14-year analysis from 2001 to 2014","volume":"61","author":"Isath","year":"2021","journal-title":"J Intervent Card Electrophysiol"},{"issue":"5","key":"10.1016\/j.ipej.2025.10.008_bib27","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s10840-023-01469-0","article-title":"Fluoroless catheter ablation of atrial fibrillation: a step-by-step workflow","volume":"66","author":"Enriquez","year":"2023","journal-title":"J Intervent Card Electrophysiol"},{"issue":"6","key":"10.1016\/j.ipej.2025.10.008_bib28","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/ehjci\/jeaf078","article-title":"Imaging assessment after percutaneous left atrial appendage closure: from immediate to long-term follow-up","volume":"26","author":"Cepas-Guill\u00e9n","year":"2025","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.ipej.2025.10.008_bib29","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/eurheartj\/ehad828","article-title":"Residual leaks following percutaneous left atrial appendage occlusion and outcomes: a meta-analysis","volume":"45","author":"Samaras","year":"2023","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.ipej.2025.10.008_bib30","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.jacep.2018.09.007","article-title":"Incidence and clinical impact of device-related thrombus following percutaneous left atrial appendage occlusion: a meta-analysis","volume":"4","author":"Alkhouli","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"issue":"4","key":"10.1016\/j.ipej.2025.10.008_bib31","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jacc.2021.04.098","article-title":"Predictors of device-related thrombus following percutaneous left atrial appendage occlusion","volume":"78","author":"Simard","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.ipej.2025.10.008_bib32","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/CIRCULATIONAHA.118.035090","article-title":"Device-related thrombus after left atrial appendage closure: incidence, predictors, and outcomes","volume":"138","author":"Dukkipati","year":"2018","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ipej.2025.10.008_bib33","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/europace\/euab065","article-title":"2021 European heart rhythm association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"23","author":"Steffel","year":"2021","journal-title":"Europace"},{"issue":"8","key":"10.1016\/j.ipej.2025.10.008_bib34","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.19102\/icrm.2018.090801","article-title":"Periprocedural use of oral anticoagulation therapy in patients undergoing atrial fibrillation ablation","volume":"9","author":"Maraj","year":"2018","journal-title":"J Innov Card Rhythm Manag"},{"issue":"6","key":"10.1016\/j.ipej.2025.10.008_bib35","doi-asserted-by":"crossref","DOI":"10.31083\/RCM39233","article-title":"Anticoagulation for stroke prevention in patients with atrial fibrillation: a review of the literature and current guidelines","volume":"26","author":"Vyas","year":"2025","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.ipej.2025.10.008_bib36","article-title":"Intraprocedural activated clotting time and heparin dosage in pulsed field ablation of paroxysmal atrial fibrillation","volume":"12","author":"Ma","year":"2025","journal-title":"Front Cardiovasc Med"},{"issue":"25","key":"10.1016\/j.ipej.2025.10.008_bib37","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1161\/CIRCULATIONAHA.113.006426","volume":"129","author":"Di Biase","year":"2014","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ipej.2025.10.008_bib38","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.hrthm.2014.03.003","volume":"11","author":"Di Biase","year":"2014","journal-title":"Heart Rhythm"},{"issue":"23","key":"10.1016\/j.ipej.2025.10.008_bib39","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1161\/CIRCULATIONAHA.109.921320","article-title":"Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio","volume":"121","author":"Di Biase","year":"2010","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.ipej.2025.10.008_bib40","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa1701005","article-title":"Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation","volume":"376","author":"Calkins","year":"2017","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ipej.2025.10.008_bib41","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jacep.2018.08.003","article-title":"Asymptomatic cerebral infarction during catheter ablation for atrial fibrillation: comparing uninterrupted rivaroxaban and warfarin (ASCERTAIN)","volume":"4","author":"Kimura","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"issue":"28","key":"10.1016\/j.ipej.2025.10.008_bib42","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/eurheartj\/ehv177","article-title":"Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation","volume":"36","author":"Cappato","year":"2015","journal-title":"Eur Heart J"},{"issue":"32","key":"10.1016\/j.ipej.2025.10.008_bib43","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1093\/eurheartj\/ehy176","article-title":"Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation","volume":"39","author":"Kirchhof","year":"2018","journal-title":"Eur Heart J"},{"issue":"36","key":"10.1016\/j.ipej.2025.10.008_bib44","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1093\/eurheartj\/ehz190","article-title":"Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial","volume":"40","author":"Hohnloser","year":"2019","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.ipej.2025.10.008_bib45","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/jce.14052","article-title":"Oral anticoagulation after catheter ablation of atrial fibrillation and the associated risk of thromboembolic events and intracranial hemorrhage: a systematic review and meta-analysis","volume":"30","author":"Romero","year":"2019","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"6","key":"10.1016\/j.ipej.2025.10.008_bib46","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jacep.2018.04.006","article-title":"Perioperative safety and efficacy of different anticoagulation strategies with direct oral anticoagulants in pulmonary vein isolation: a meta-analysis","volume":"4","author":"Gorla","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"issue":"3","key":"10.1016\/j.ipej.2025.10.008_bib47","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10840-020-00754-6","article-title":"Meta-analysis of the safety and efficacy of using minimally interrupted novel oral anticoagulants in patients undergoing catheter ablation for atrial fibrillation","volume":"60","author":"Mao","year":"2021","journal-title":"J Intervent Card Electrophysiol"},{"issue":"12","key":"10.1016\/j.ipej.2025.10.008_bib48","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1093\/europace\/euab175","article-title":"Meta-analysis of controlled studies on minimally interrupted vs. continuous use of non-vitamin K antagonist oral anticoagulants in catheter ablation for atrial fibrillation","volume":"23","author":"van Vugt","year":"2021","journal-title":"Europace"},{"issue":"6","key":"10.1016\/j.ipej.2025.10.008_bib49","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/jce.12975","article-title":"Clinical impact of heparin kinetics during catheter ablation of atrial fibrillation: meta-analysis and meta-regression","volume":"27","author":"Briceno","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"7","key":"10.1016\/j.ipej.2025.10.008_bib50","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/europace\/euz004","article-title":"Venous access-site closure with vascular closure device vs. manual compression in patients undergoing catheter ablation or left atrial appendage occlusion under uninterrupted anticoagulation: a multicentre experience on efficacy and complications","volume":"21","author":"Mohanty","year":"2019","journal-title":"Europace"},{"issue":"3","key":"10.1016\/j.ipej.2025.10.008_bib51","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.1320","article-title":"Discontinuation of oral anticoagulation after successful atrial fibrillation ablation","volume":"8","author":"Iwawaki","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"42","key":"10.1016\/j.ipej.2025.10.008_bib52","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000035518","article-title":"It can be safe to discontinue oral anticoagulants after successful atrial fibrillation ablation: a systematic review and meta-analysis of cohort studies","volume":"102","author":"Wang","year":"2023","journal-title":"Medicine (Baltim)"},{"issue":"6","key":"10.1016\/j.ipej.2025.10.008_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253709","article-title":"Discontinuation of oral anticoagulation therapy after successful atrial fibrillation ablation: a systematic review and meta-analysis of prospective studies","volume":"16","author":"Liu","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ipej.2025.10.008_bib54","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2025.14679","article-title":"Long-term anticoagulation discontinuation after catheter ablation for atrial fibrillation: the ALONE-AF randomized clinical trial","author":"Kim","year":"2025","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.ipej.2025.10.008_bib55","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jacc.2019.06.045","article-title":"Stroke risk in patients with atrial fibrillation undergoing electrical isolation of the left atrial appendage","volume":"74","author":"Di","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ipej.2025.10.008_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2025.07.035","article-title":"Pulsed field ablation and periprocedural stroke risk-A step in the right direction","author":"Hochstadt","year":"2025","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ipej.2025.10.008_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2025.03.1952","article-title":"Management of oral anticoagulation after pulsed field ablation for atrial fibrillation: insights from a multicenter study","author":"Mohanty","year":"2025","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.ipej.2025.10.008_bib58","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/CIRCULATIONAHA.123.064959","article-title":"Safety and effectiveness of pulsed field ablation to treat atrial fibrillation: one-year outcomes from the MANIFEST-PF registry","volume":"148","author":"Turagam","year":"2023","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ipej.2025.10.008_bib59","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad185","article-title":"EUropean real-world outcomes with pulsed field ablatiOn in patients with symptomatic atRIAl fibrillation: lessons from the multi-centre EU-PORIA registry","volume":"25","author":"Schmidt","year":"2023","journal-title":"Europace"},{"issue":"7","key":"10.1016\/j.ipej.2025.10.008_bib60","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1038\/s41591-024-03114-3","article-title":"Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study","volume":"30","author":"Ekanem","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.ipej.2025.10.008_bib61","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ahj.2025.07.013","article-title":"Pulsed field ablation-related hemoglobinuria and acute kidney injury: insights and strategies for effective management","volume":"290","author":"Tamirisa","year":"2025","journal-title":"Am Heart J"},{"issue":"10","key":"10.1016\/j.ipej.2025.10.008_bib62","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.124.012732","article-title":"Characterization and clinical significance of hemolysis after pulsed field ablation for atrial fibrillation: results of a multicenter analysis","volume":"17","author":"Popa","year":"2024","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"23","key":"10.1016\/j.ipej.2025.10.008_bib63","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1161\/CIRCULATIONAHA.122.062752","article-title":"Direct oral anticoagulants versus warfarin across the spectrum of kidney function: patient-level network meta-analyses from COMBINE AF","volume":"147","author":"Harrington","year":"2023","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ipej.2025.10.008_bib64","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.034176","article-title":"Anticoagulation for patients with concomitant atrial fibrillation and end\u2010stage renal disease: a systematic review and network meta\u2010analysis","volume":"13","author":"Kao","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.ipej.2025.10.008_bib65","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ipej.2025.10.008_bib66","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"January","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ipej.2025.10.008_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcha.2022.101055","article-title":"Age-dependent risk for thromboembolism in atrial fibrillation: the fushimi AF registry","volume":"41","author":"Esato","year":"2022","journal-title":"IJC Heart & Vasculature"},{"issue":"8","key":"10.1016\/j.ipej.2025.10.008_bib68","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1532-5415.2006.00828.x","article-title":"Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study","volume":"54","author":"Fang","year":"2006","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"10.1016\/j.ipej.2025.10.008_bib69","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.amjcard.2019.02.060","article-title":"Meta-analysis of direct-acting oral anticoagulants compared with warfarin in patients >75 years of age","volume":"123","author":"Malik","year":"2019","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.ipej.2025.10.008_bib70","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.7326\/M20-7141","article-title":"Frailty and clinical outcomes of direct oral anticoagulants versus warfarin in older adults with atrial fibrillation : a cohort study","volume":"174","author":"Kim","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ipej.2025.10.008_bib71","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fmed.2020.00107","article-title":"Efficacy and safety of direct oral anticoagulants in elderly patients with atrial fibrillation: a network meta-analysis","volume":"7","author":"Deng","year":"2020","journal-title":"Front Med"},{"issue":"4","key":"10.1016\/j.ipej.2025.10.008_bib72","first-page":"279","article-title":"Safety of switching from a vitamin K antagonist to a non-vitamin K antagonist oral anticoagulant in frail older patients with atrial fibrillation: results of the FRAIL-AF randomized controlled trial","volume":"149","author":"Joosten","year":"2024","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ipej.2025.10.008_bib73","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1161\/CIRCULATIONAHA.123.067555","article-title":"Switching to direct anticoagulation or continued Vitamin-K antagonists in frail patients with atrial fibrillation in whom Vitamin-K antagonists are tolerated?","volume":"149","author":"Wallentin","year":"2024","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.ipej.2025.10.008_bib74","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJMoa2408308","article-title":"Left atrial appendage closure after ablation for atrial fibrillation","volume":"392","author":"Wazni","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ipej.2025.10.008_bib75","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ahj.2024.02.015","article-title":"Strategy to optimize PeriproCeduraL AnticOagulation in structural transseptal interventions: design and rationale of the STOP CLOT trial","volume":"271","author":"Pr\u0119gowski","year":"2024","journal-title":"Am Heart J"},{"issue":"32","key":"10.1016\/j.ipej.2025.10.008_bib76","first-page":"2914","article-title":"Left atrial appendage closure for stroke prevention in atrial fibrillation: current status and perspectives","volume":"45","author":"Landmesser","year":"2024","journal-title":"Eur Heart J"},{"issue":"9689","key":"10.1016\/j.ipej.2025.10.008_bib77","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ipej.2025.10.008_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ipej.2025.10.008_bib79","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026295","article-title":"Two-year outcomes with a next-generation left atrial appendage device: final results of the PINNACLE FLX trial","volume":"12","author":"Doshi","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"15","key":"10.1016\/j.ipej.2025.10.008_bib80","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.jcin.2023.06.022","article-title":"3-Year outcomes from the amplatzer amulet left atrial appendage occluder randomized controlled trial (amulet IDE)","volume":"16","author":"Lakkireddy","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.ipej.2025.10.008_bib81","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.118.006841","article-title":"Evaluating real-world clinical outcomes in atrial fibrillation patients receiving the WATCHMAN left atrial appendage closure technology: final 2-Year outcome data of the EWOLUTION trial focusing on history of stroke and hemorrhage","volume":"12","author":"Boersma","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"18","key":"10.1016\/j.ipej.2025.10.008_bib82","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jacc.2022.02.047","article-title":"Antithrombotic therapy after left atrial appendage occlusion in patients with atrial fibrillation","volume":"79","author":"Freeman","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ipej.2025.10.008_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2021.10.023","article-title":"4-Year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation","volume":"79","author":"Osmancik","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ipej.2025.10.008_bib84","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.123.067599","article-title":"One-year outcomes after amulet or watchman device for percutaneous left atrial appendage closure: a prespecified analysis of the SWISS-APERO randomized clinical trial","volume":"149","author":"Galea","year":"2024","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ipej.2025.10.008_bib85","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/jamacardio.2024.2335","article-title":"Low-dose direct oral anticoagulation vs dual antiplatelet therapy after left atrial appendage occlusion: the ADALA randomized clinical trial","volume":"9","author":"Freixa","year":"2024","journal-title":"JAMA Cardiology"},{"issue":"15","key":"10.1016\/j.ipej.2025.10.008_bib86","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jcin.2015.08.035","article-title":"Bleeding outcomes after left atrial appendage closure compared with long-term warfarin: a pooled, patient-level analysis of the WATCHMAN randomized trial experience","volume":"8","author":"Price","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"18","key":"10.1016\/j.ipej.2025.10.008_bib87","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1161\/CIRCULATIONAHA.120.050117","article-title":"Primary outcome evaluation of a next-generation left atrial appendage closure device: results from the PINNACLE FLX trial","volume":"143","author":"Kar","year":"2021","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.ipej.2025.10.008_bib88","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.121.057063","article-title":"Amplatzer amulet left atrial appendage occluder versus watchman device for stroke prophylaxis (amulet IDE): a randomized, controlled trial","volume":"144","author":"Lakkireddy","year":"2021","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ipej.2025.10.008_bib89","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.120.010195","article-title":"Device-related thrombus after left atrial appendage closure: data on thrombus characteristics, treatment strategies, and clinical outcomes from the EUROC-DRT-Registry","volume":"14","author":"Sedaghat","year":"2021","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ipej.2025.10.008_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2025.05.049","article-title":"SCAI\/HRS technical review on transcatheter left atrial appendage occlusion","author":"Cronin","year":"2025","journal-title":"Heart Rhythm"},{"issue":"21","key":"10.1016\/j.ipej.2025.10.008_bib91","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.jcin.2022.09.001","article-title":"Peridevice leak after transcatheter left atrial appendage occlusion: an analysis of the amulet IDE trial","volume":"15","author":"Price","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.ipej.2025.10.008_bib92","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jacc.2022.04.062","article-title":"Impact of peridevice leak on 5-Year outcomes after left atrial appendage closure","volume":"80","author":"Dukkipati","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ipej.2025.10.008_bib93","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jacep.2022.03.001","article-title":"Clinical impact of residual leaks following left atrial appendage occlusion: insights from the NCDR LAAO registry","volume":"8","author":"Alkhouli","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.ipej.2025.10.008_bib94","doi-asserted-by":"crossref","unstructured":"Jacquemyn X, S\u00e1 MP, Korsholm K, et al. Outcomes of left atrial appendage patency after device closure detected by cardiac CT. JACC (J Am Coll Cardiol): Cardiovascular Imaging. 0(0)doi:doi:10.1016\/j.jcmg.2025.07.018.","DOI":"10.1016\/j.jcmg.2025.07.018"},{"issue":"1","key":"10.1016\/j.ipej.2025.10.008_bib95","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad361","article-title":"Major in-hospital complications after catheter ablation of cardiac arrhythmias: individual case analysis of 43 031 procedures","volume":"26","author":"Eckardt","year":"2023","journal-title":"Europace"},{"issue":"19","key":"10.1016\/j.ipej.2025.10.008_bib96","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12196183","article-title":"Antiplatelet and anti-coagulation therapy for left-sided catheter ablations: what is beyond atrial fibrillation?","volume":"12","author":"Nesti","year":"2023","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.ipej.2025.10.008_bib97","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/j.hrthm.2019.03.002","article-title":"2019 HRS\/EHRA\/APHRS\/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias","volume":"17","author":"Cronin","year":"2020","journal-title":"Heart Rhythm"},{"issue":"12","key":"10.1016\/j.ipej.2025.10.008_bib98","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.jacep.2021.07.010","article-title":"Safety\/efficacy of DOAC versus aspirin for reduction of risk of cerebrovascular events following VT ablation","volume":"7","author":"Lakkireddy","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"issue":"24","key":"10.1016\/j.ipej.2025.10.008_bib99","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","article-title":"Transcatheter mitral-valve repair in patients with heart failure","volume":"379","author":"Stone","year":"2018","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.ipej.2025.10.008_bib100","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1161\/CIRCULATIONAHA.121.054305","article-title":"Antithrombotic therapy in patients undergoing transcatheter interventions for structural heart disease","volume":"144","author":"Calabr\u00f2","year":"2021","journal-title":"Circulation"}],"container-title":["Indian Pacing and Electrophysiology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0972629225001664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0972629225001664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T23:03:09Z","timestamp":1764975789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0972629225001664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":100,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0972629225001664"],"URL":"https:\/\/doi.org\/10.1016\/j.ipej.2025.10.008","relation":{},"ISSN":["0972-6292"],"issn-type":[{"type":"print","value":"0972-6292"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antithrombotic management in left sided- ablation and appendage device-closure procedures","name":"articletitle","label":"Article Title"},{"value":"Indian Pacing and Electrophysiology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ipej.2025.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Indian Heart Rhythm Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}